Cargando…
Tumor Treating Fields dually activate STING and AIM2 inflammasomes to induce adjuvant immunity in glioblastoma
Tumor Treating Fields (TTFields), an approved therapy for glioblastoma (GBM) and malignant mesothelioma, employ noninvasive application of low-intensity, intermediate-frequency, alternating electric fields to disrupt the mitotic spindle, leading to chromosome missegregation and apoptosis. Emerging e...
Autores principales: | Chen, Dongjiang, Le, Son B., Hutchinson, Tarun E., Calinescu, Anda-Alexandra, Sebastian, Mathew, Jin, Dan, Liu, Tianyi, Ghiaseddin, Ashley, Rahman, Maryam, Tran, David D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Clinical Investigation
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9012294/ https://www.ncbi.nlm.nih.gov/pubmed/35199647 http://dx.doi.org/10.1172/JCI149258 |
Ejemplares similares
-
Inflammasome-independent functions of AIM2
por: Zhao, Junjie, et al.
Publicado: (2021) -
Roles of AIM2 Gene and AIM2 Inflammasome in the Pathogenesis and Treatment of Psoriasis
por: Wang, Jieyi, et al.
Publicado: (2022) -
The Role of AIM2 Inflammasome in Knee Osteoarthritis
por: Yang, Jiyong, et al.
Publicado: (2022) -
A Dually Flat Embedding of Spacetime
por: Naudts, Jan
Publicado: (2023) -
Inflammasomes as Targets for Adjuvants
por: Ivanov, Konstantin, et al.
Publicado: (2020)